![Jack T. Nguyen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jack T. Nguyen
Plus aucun poste en cours
Historique de carrière de Jack T. Nguyen
Anciens postes connus de Jack T. Nguyen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Catalyst Bioscience, Inc. /Old/
![]() Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA. | Fondateur | - | - |
ADAMAS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2007 | - |
Formation de Jack T. Nguyen
The University of California, San Francisco | Doctorate Degree |
University of California, Berkeley | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Adamas Pharmaceuticals LLC
![]() Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Catalyst Bioscience, Inc. /Old/
![]() Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Jack T. Nguyen
- Expérience